Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Controlled Human Malaria Infection (CHMI) to Assess Human Immunity to P. Falciparum Using Sporozoites Administered by Direct Venous Inoculation

NCT02739763 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT02739763
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02739763 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Controlled Human Malaria Infection (CHMI) to Assess Human Immunity to P. Falciparum Using Sporozoites Administered by Direct Venous Inoculation
Lead sponsor
University of Oxford
Phase
Phase 1
Overall status
Unknown status
Start date
May 31, 2016
Completion date
November 30, 2020
Enrollment
200 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

malaria